The Dutch paints company reported a fall in third-quarter net profit, missing consensus views, and said it expected full-year earnings at the lower end of its guidance.
Kuehne + Nagel reported a forecast-beating rise in third-quarter profitability as efficiency measures and higher volumes helped boost the performance of its sea and air logistics businesses.
Roche said it would increase its dividend after its hemophilia injection Hemlibra and multiple sclerosis treatment Ocrevus lifted sales in the first nine months of the year.
Thales posted orders above analysts' expectations for the first nine months of the year as its defense and security business continued to benefit from robust military spending amid high geopolitical tensions.